Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1419-1428

  Albrecht, J A ^a,b   Dong, Y ^a   Wang, J ^a   Breeden, C ^a   Farris, A B ^b   Lukacher, A E ^b   Newell, K A ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney transplant; MHC; mouse; nephropathy; polyomavirus

Indexed keywords

CREATININE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; COLD ISCHEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; GRAFT SURVIVAL; HISTOPATHOLOGY; INFECTION; INOCULATION; KIDNEY ALLOGRAFT; KIDNEY ISCHEMIA; MOUSE; NONHUMAN; POLYOMAVIRUS ASSOCIATED ALLOGRAFT NEPHROPATHY; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL RATE; VIRUS LOAD;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; POLYOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84862779345     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04005.x     Document Type: Article

References (44)

1. Ramos E, Drachenberg CB, Wali R, Hirsch HH,. The decade of polyomavirus BK-associated nephropathy: State of affairs. Transplantation 2009; 87: 621-630.
2. Bohl DL, Brennan DC,. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007; 2 (Suppl 1): S36-S46.
3. Smith F, Panek R, Kiberd BA,. Screening to prevent polyoma virus nephropathy in kidney transplantation: A cost analysis. Am J Transplant 2009; 9: 2177-2179.
4. Dharnidharka VR, Cherikh WS, Abbott KC,. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation 2009; 87: 1019-1026.
5. Dharnidharka VR, Cherikh WS, Neff R, Cheng Y, Abbott KC,. Retransplantation after BK virus nephropathy in prior kidney transplant: An OPTN database analysis. Am J Transplant 2010; 10: 1312-1315.
6. Kausman JY, Somers GR, Francis DM, Jones CL,. Association of renal adenocarcinoma and BK virus nephropathy post transplantation. Pediatr Nephrol 2004; 19: 459-462.
7. Narayanan M, Szymanski J, Slavcheva E, et al,. BK virus associated renal cell carcinoma: Case presentation with optimized PCR and other diagnostic tests. Am J Transplant 2007; 7: 1666-1671.
8. Egli A, Helmersen DS, Taub K, Hirsch HH, Johnson A,. Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. Am J Transplant 2010; 10: 2324-2330.
9. Loeches B, Valerio M, Palomo J, Bouza E, Munoz P,. BK virus in heart transplant recipients: A prospective study. J Heart Lung Transplant 2011; 30: 109-111.
10. Loeches B, Valerio M, Perez M, et al,. BK virus in liver transplant recipients: A prospective study. Transplant Proc 2009; 41: 1033-1037.
11. Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA,. Treatment of polyomavirus infection in kidney transplant recipients: A systematic review. Transplantation 2010; 89: 1057-1070.
12. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC,. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant 2010; 10: 407-415.
13. Schaub S, Hirsch HH, Dickenmann M, et al,. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus- associated nephropathy. Am J Transplant 2010; 10: 2615-2623.
14. Han Lee ED, Kemball CC, Wang J, et al,. A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am J Transplant 2006; 6 (5 Pt 1): 913-922.
15. Rowe WP,. The epidemiology of mouse polyoma virus infection. Bacteriol Rev 1961; 25: 18-31.
16. Lukacher AE, Wilson CS,. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J Immunol 1998; 160: 1724-1734.
17. Drake DR, 3rd, Lukacher AE,. Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 1998; 252: 275-284.
18. Wilson JJ, Lin E, Pack CD, et al,. Gamma interferon controls mouse polyomavirus infection in vivo. J Virol 2011; 85: 10126-10134.
19. Bickerstaff A, Pelletier R, Wang JJ, et al,. An experimental model of acute humoral rejection of renal allografts associated with concomitant cellular rejection. Am J Pathol 2008; 173: 347-357.
20. Kemball CC, Lee ED, Vezys V, Pearson TC, Larsen CP, Lukacher AE,. Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection. J Immunol 2005; 174: 7950-7960.
21. Solez K, Colvin RB, Racusen LC, et al,. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760.
22. Racusen LC, Solez K, Colvin RB, et al,. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
23. Helantera I, Egli A, Koskinen P, Lautenschlager I, Hirsch HH,. Viral impact on long-term kidney graft function. Infect Dis Clin North Am 2010; 24: 339-371.
24. Cornell LD, Smith RN, Colvin RB,. Kidney transplantation: Mechanisms of rejection and acceptance. Annu Rev Pathol 2008; 3: 189-220.
25. Cheng O, Thuillier R, Sampson E, et al,. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006; 6: 2292-2306.
26. Mannon RB, Kopp JB, Ruiz P, et al,. Chronic rejection of mouse kidney allografts. Kidney Int 1999; 55: 1935-1944.
27. Nickeleit V, Hirsch HH, Binet IF, et al,. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080-1089.
28. Celik B, Randhawa PS,. Glomerular changes in BK virus nephropathy. Hum Pathol 2004; 35: 367-370.
29. Atencio IA, Shadan FF, Zhou XJ, Vaziri ND, Villarreal LP,. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol 1993; 67: 1424-1432.
30. Gosert R, Rinaldo CH, Funk GA, et al,. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 2008; 205: 841-852.
31. Andrews NP, Pack CD, Vezys V, Barber GN, Lukacher AE,. Early virus-associated bystander events affect the fitness of the CD8 T cell response to persistent virus infection. J Immunol 2007; 178: 7267-7275.
32. Awadalla Y, Randhawa P, Ruppert K, Zeevi A, Duquesnoy RJ,. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant 2004; 4: 1691-1696.
33. Drachenberg CB, Papadimitriou JC, Mann D, Hirsch HH, Wali R, Ramos E,. Negative impact of human leukocyte antigen matching in the outcome of polyomavirus nephropathy. Transplantation 2005; 80: 276-278.
34. Bohl DL, Storch GA, Ryschkewitsch C, et al,. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213-2221.
35. Karrer U, Althage A, Odermatt B, Hengartner H, Zinkernagel RM,. Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: Structural defect of secondary lymphoid organs and functional B cell defect. Eur J Immunol 2000; 30: 2799-2807.
36. Kean JM, Rao S, Wang M, Garcea RL,. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009; 5: e1000363.
37. Ginevri F, De Santis R, Comoli P, et al,. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75: 1266-1270.
38. Haysom L, Rosenberg AR, Kainer G, et al,. BK viral infection in an Australian pediatric renal transplant population. Pediatr Transplant 2004; 8: 480-484.
39. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP,. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004; 4: 2109-2117.
40. Acott PD, Hirsch HH,. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007; 22: 1243-1250.
41. Matzinger P,. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045.
42. Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM,. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005; 5: 1926-1933.
43. Priftakis P, Bogdanovic G, Tyden G, Dalianis T,. Polyomaviruria in renal transplant patients is not correlated to the cold ischemia period or to rejection episodes. J Clin Microbiol 2000; 38: 406-407.
44. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP,. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834-1839.